Most Recent
The Australian Competition and Consumer Commission has brought legal action against three major Australian internet providers for allegedly misleading hundreds of thousands of NBN customers.
SkyCity's announcement to shareholders about an employee's interrogation by Chinese gambling authorities made little difference to the NZ casino operator's share price, Crown Resorts has told a court in expert evidence ahead of a looming class action trial.
The former director of Sydney financial planning practice Hillross Bella Vista has been conditionally released without a conviction recorded after pleading guilty to falsifying documents uncovered during an investigation by the Australian Securities and Investments Commission.
The judge overseeing class actions against Commonwealth Bank over its money laundering compliance failures has threatened to force the parties to go to trial by a certain date if they can't agree to "sensible" time limits to ready the case for hearing, noting he would reach retirement age in 2024.
A judge has slammed an "absurd" class action settlement offer made by pelvic mesh device maker Astora Women's Health that would require Shine Lawyers to provide the company with indemnities, saying "no rational judge" would approve it.
The Office of the Australian Information Commissioner is investigating whether Optus breached privacy law after the telco wrongly published customers’ personal details in the White Pages in 2019.
A judge has dismissed jailed property developer Salim Mehajer’s defamation lawsuit against broadcaster Seven, saying delays in fixing significant defects in his case amounted to an abuse of process.
Sydney's ongoing COVID-19 lockdown has created "logistical" difficulties delaying the release of a long awaited judgment in the ACCC's consumer law case against collapsed private college Phoenix Institute, which was accused of misleading students through the marketing of its courses.
Pharmaceutical giant Bristol-Myers Squibb will fight a case brought by Merck Sharp & Dohme alleging misuse of market power over stage IV melanoma treatments, telling the Federal Court on Friday it denied its rival's claims.
Six of Australia's biggest financial services firms have paid or offered to pay a total of $1.86 billion to customers who were wrongly charged fees for no service or were given bad advice.